CD95-mediated apoptosis and DNA fragmentation in MS.

Standard

CD95-mediated apoptosis and DNA fragmentation in MS. / Heesen, C; Georghiu, S; Gbadamosi, Joystone; Schoser, B G.

in: ACTA NEUROL SCAND, Jahrgang 102, Nr. 5, 5, 2000, S. 333-336.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Heesen, C, Georghiu, S, Gbadamosi, J & Schoser, BG 2000, 'CD95-mediated apoptosis and DNA fragmentation in MS.', ACTA NEUROL SCAND, Jg. 102, Nr. 5, 5, S. 333-336. <http://www.ncbi.nlm.nih.gov/pubmed/11083512?dopt=Citation>

APA

Heesen, C., Georghiu, S., Gbadamosi, J., & Schoser, B. G. (2000). CD95-mediated apoptosis and DNA fragmentation in MS. ACTA NEUROL SCAND, 102(5), 333-336. [5]. http://www.ncbi.nlm.nih.gov/pubmed/11083512?dopt=Citation

Vancouver

Heesen C, Georghiu S, Gbadamosi J, Schoser BG. CD95-mediated apoptosis and DNA fragmentation in MS. ACTA NEUROL SCAND. 2000;102(5):333-336. 5.

Bibtex

@article{ce3ce71c43304e85a29595c63440b396,
title = "CD95-mediated apoptosis and DNA fragmentation in MS.",
abstract = "OBJECTIVE: To investigate possible associations of soluble CD95 (sCD95) serum levels and DNA defragmentation with different MS disease stages and activities. METHODS: Sera of 114 patients were analysed by an ELISA technique for sCD95. In a subgroup of 18 relapsing-remitting MS patients and controls we studied DNA fragmentation by the TUNEL-method in CSF cytospins. RESULTS: sCD95 was detectable in sera of MS patients, healthy controls and meningitis patients without significant differences. CSF specimens showed modest amounts of apoptotic cells in MS and controls. CONCLUSION: We could not demonstrate an association of MS disease course or activity with the expression of sCD95 in sera. DNA fragmentation in the CSF was not significantly enhanced compared to controls. Thus the analysed markers of programmed cell death appear not suitable to monitor MS disease courses.",
author = "C Heesen and S Georghiu and Joystone Gbadamosi and Schoser, {B G}",
year = "2000",
language = "Deutsch",
volume = "102",
pages = "333--336",
journal = "ACTA NEUROL SCAND",
issn = "0001-6314",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - CD95-mediated apoptosis and DNA fragmentation in MS.

AU - Heesen, C

AU - Georghiu, S

AU - Gbadamosi, Joystone

AU - Schoser, B G

PY - 2000

Y1 - 2000

N2 - OBJECTIVE: To investigate possible associations of soluble CD95 (sCD95) serum levels and DNA defragmentation with different MS disease stages and activities. METHODS: Sera of 114 patients were analysed by an ELISA technique for sCD95. In a subgroup of 18 relapsing-remitting MS patients and controls we studied DNA fragmentation by the TUNEL-method in CSF cytospins. RESULTS: sCD95 was detectable in sera of MS patients, healthy controls and meningitis patients without significant differences. CSF specimens showed modest amounts of apoptotic cells in MS and controls. CONCLUSION: We could not demonstrate an association of MS disease course or activity with the expression of sCD95 in sera. DNA fragmentation in the CSF was not significantly enhanced compared to controls. Thus the analysed markers of programmed cell death appear not suitable to monitor MS disease courses.

AB - OBJECTIVE: To investigate possible associations of soluble CD95 (sCD95) serum levels and DNA defragmentation with different MS disease stages and activities. METHODS: Sera of 114 patients were analysed by an ELISA technique for sCD95. In a subgroup of 18 relapsing-remitting MS patients and controls we studied DNA fragmentation by the TUNEL-method in CSF cytospins. RESULTS: sCD95 was detectable in sera of MS patients, healthy controls and meningitis patients without significant differences. CSF specimens showed modest amounts of apoptotic cells in MS and controls. CONCLUSION: We could not demonstrate an association of MS disease course or activity with the expression of sCD95 in sera. DNA fragmentation in the CSF was not significantly enhanced compared to controls. Thus the analysed markers of programmed cell death appear not suitable to monitor MS disease courses.

M3 - SCORING: Zeitschriftenaufsatz

VL - 102

SP - 333

EP - 336

JO - ACTA NEUROL SCAND

JF - ACTA NEUROL SCAND

SN - 0001-6314

IS - 5

M1 - 5

ER -